HighTower Advisors’s Teladoc Health TDOC Stock Holding History

HighTower Advisors’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-180	Closed	-$12.2K	–	3848
2023 Q3	$12.2K	Buy	+180	New	+$4.2K	﹤0.01%	3371
2021 Q4	–	Sell	-200	Closed	-$3K	–	3475
2021 Q3	$3K	Buy	200 +100	+100%	+$14.6K	﹤0.01%	3089
2021 Q2	$1K	Buy	100 +97	+3,233%	+$15.7K	﹤0.01%	3124
2021 Q1	$6K	Sell	3 -5	-63%	-$1.16K	﹤0.01%	2951
2020 Q4	$7K	Buy	+8	New	+$1.63K	﹤0.01%	2530
2020 Q3	–	Sell	-400	Closed	-$1K	–	2694
2020 Q2	$1K	Buy	+400	New	+$70.1K	﹤0.01%	2417

Other funds holding TDOC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HighTower Advisors's TDOC Position: Q1 2026 in Review

HighTower Advisors reduced its Teladoc Health (TDOC) stake by 25% in Q1 2026, selling an estimated $26.6K and leaving 13,915 shares worth $75.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3667.

HighTower Advisors first reported a position in TDOC in Q2 2018 and has held it in 32 quarters since. The position peaked at $11.5M in Q4 2021. 322 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.

HighTower Advisors held 13,915 shares of Teladoc Health worth $75.8K as of Q1 2026.
HighTower Advisors sold 4,732 Teladoc Health shares in Q1 2026, an estimated $26.6K.
Teladoc Health made up ﹤0.01% of HighTower Advisors's portfolio in Q1 2026, its #3667 holding.
HighTower Advisors first reported a position in Teladoc Health in Q2 2018 and has held it in 32 quarters since.
HighTower Advisors's Teladoc Health position peaked at $11.5M in Q4 2021.
322 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.